HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan-Maarten van Woerkom Selected Research

Sjogren's Syndrome (Sjogren Syndrome)

12/2012Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan-Maarten van Woerkom Research Topics

Disease

1Necrosis
12/2012
1Sjogren's Syndrome (Sjogren Syndrome)
12/2012

Drug/Important Bio-Agent (IBA)

1Leflunomide (Arava)FDA LinkGeneric
12/2012
1InterferonsIBA
12/2012
1InterleukinsIBA
12/2012
1Interleukin-4 (Interleukin 4)IBA
12/2012
1Interleukin-7 Receptors (Interleukin 7 Receptor)IBA
12/2012